PI-55
PI-55 is a specific cytokinin receptor inhibitor. PI-55 is structurally related to 6-benzylaminopurine (BAP) and was shown to inhibit competitively BAP binding on Arabidopsis-specific receptors CRE1/AHK4 and AHK3. PI-55 inhibits cytokinins induced haustorium formation and increased parasite aggressiveness[1].
Product Specifications
CAS Number
1122579-42-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/pi-55.html
Concentration
10mM
Purity
98.89
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
OC1=C(CNC2=C3N=CNC3=NC=N2)C=CC=C1C
Molecular Formula
C13H13N5O
Molecular Weight
255.28
Precautions
H302, H315, H319, H335
References & Citations
[1] Goyet V, et al. Haustorium initiation in the obligate parasitic plant Phelipanche ramosa involves a host-exudated cytokinin signal. J Exp Bot. 2017;68 (20) :5539-5552.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HP230377 200 Reactions
COL13A1 Human qPCR Primer Pair (NM_001130103)
Sign In for Pricing
View Details 
TRC-D435935-50MG 50 mg
5,6-Dichloropurine-1-(2,3,5-tri-O-acetyl-Beta-D-ribofuanosyl)-1H-benzimidazole
Sign In for Pricing
View Details 